Cytochrome P450 Enzyme Metabolites in Lead Discovery and Development
Authors:
- 3 October 2014
- book chapter
- Published by Elsevier
- Vol. 49, 347-359
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- The tamoxifen metabolite norendoxifen is a potent and selective inhibitor of aromatase (CYP19) and a potential lead compound for novel therapeutic agentsBreast Cancer Research and Treatment, 2011
- Constructing de Novo Biosynthetic Pathways for Chemical Synthesis inside Living CellsBiochemistry, 2011
- Hydrocarbon Hydroxylation by Cytochrome P450 EnzymesChemical Reviews, 2009
- Production of the antimalarial drug precursor artemisinic acid in engineered yeastNature, 2006
- Clinical Pharmacokinetics of AtorvastatinClinical Pharmacokinetics, 2003
- Oxidation of Indole by Cytochrome P450 EnzymesBiochemistry, 2000
- Clinical Pharmacokinetics of MifepristoneClinical Pharmacokinetics, 1997
- Amphotericin B: new life for an old drugTrends in Pharmacological Sciences, 1996
- Griseofulvin and its usesInternational Journal of Antimicrobial Agents, 1996
- Synthesis of the taxane ring systemJournal of the American Chemical Society, 1984